Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine
Corti, Davide, Suguitan Jr., Amorsolo L., Pinna, Debora, Silacci, Chiara, Fernandez-Rodriguez, Blanca M., Vanzetta, Fabrizia, Santos, Celia , Luke, Catherine J., Torres-Velez, Fernando J., Temperton, Nigel J., Weiss, Robin A., Sallusto, Federica , Subbarao, Kanta and Lanzavecchia, Antonio (2010) Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. The Journal of Clinical Investigation, 120 (5). pp. 1663-1673. ISSN 0021-9738 (Print), 1558-8238 (Online) (doi:10.1172/JCI41902)Full text not available from this repository.
The target of neutralizing antibodies that protect against influenza virus infection is the viral protein HA. Genetic and antigenic variation in HA has been used to classify influenza viruses into subtypes (H1–H16). The neutralizing antibody response to influenza virus is thought to be specific for a few antigenically related isolates within a given subtype. However, while heterosubtypic antibodies capable of neutralizing multiple influenza virus subtypes have been recently isolated from phage display libraries, it is not known whether such antibodies are produced in the course of an immune response to influenza virus infection or vaccine. Here we report that, following vaccination with seasonal influenza vaccine containing H1 and H3 influenza virus subtypes, some individuals produce antibodies that cross-react with H5 HA. By immortalizing IgG-expressing B cells from 4 individuals, we isolated 20 heterosubtypic mAbs that bound and neutralized viruses belonging to several HA subtypes (H1, H2, H5, H6, and H9), including the pandemic A/California/07/09 H1N1 isolate. The mAbs used different VH genes and carried a high frequency of somatic mutations. With the exception of a mAb that bound to the HA globular head, all heterosubtypic mAbs bound to acid-sensitive epitopes in the HA stem region. Four mAbs were evaluated in vivo and protected mice from challenge with influenza viruses representative of different subtypes. These findings reveal that seasonal influenza vaccination can induce polyclonal heterosubtypic neutralizing antibodies that cross-react with the swine-origin pandemic H1N1 influenza virus and with the highly pathogenic H5N1 virus.
|Additional Information:|| Acknowledgements (funding): This work was supported in part by the Swiss National Science Foundation (31003A-126027), the European Commission FP6 programme (IMECS, 201169), the Human Frontier Science Program (RGP9/2007), and the Intramural Research Program of National Institute of Allergy and Infection Diseases, NIH. A. Lanzavecchia is supported by the Helmut Horten Foundation. N.J. Temperton and R.A. Weiss are supported by the UK Medical Research Council.|
|Uncontrolled Keywords:||antibodies, immunization, influenza vaccine|
|Subjects:||R Medicine > RC Internal medicine
R Medicine > RZ Other systems of medicine
|School / Department / Research Groups:||Medway School of Pharmacy
Faculty of Engineering & Science > Medway School of Pharmacy
Faculty of Engineering & Science
|Last Modified:||27 Jul 2015 14:15|
Actions (login required)